The Cancer Letter

Inside information on cancer research and drug development

Vol.
36
No.
38
October 22, 2010Oct 22, 2010
DOWNLOAD THE PDF

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

NCI Sends A Second Letter To Groups About Carboplatin

Agency Asks GnRH Sponsors To Add Warnings On Labels

NCI Awards STRAP Grant Of $2 Million To MSKCC

Beth Israel Suspends Enrollment In Trials Following An Audit

NCCN Guidelines Retain Avastin For Breast Cancer

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

“Dollars For Docs” Database Of Pharma Payments Posted By News Organization

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account